CATALYST PHARMACEUTICA

Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra

23 янв 2023 13:25:09 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®

23 янв 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd

19 дек 2022 16:10:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update

09 ноя 2022 16:11:31 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year

07 ноя 2022 08:03:37 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022

25 окт 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients

29 сен 2022 11:18:17 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

09 сен 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference

24 авг 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update

09 авг 2022 16:26:30 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022

26 июл 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical

12 июл 2022 06:00:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

17 май 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update

10 май 2022 16:11:56 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022

25 апр 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

16 мар 2022 16:20:58 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®

11 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies

08 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 16, 2022

03 мар 2022 09:20:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio

02 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire